An2 Therapeutics, Inc. - ANTX

  1. All Sectors
  2. Manufacturing
  3. Chemicals
  4. Pharmaceutical Preparations
Latest data: 12/19/2025 10:04:48 PM
EDGAR CIK 0001880438

Buy Breakdown

Total $20,798

Sell Breakdown

Total $27,695

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
11/04/2025
11/06/2025
Eizen Joshua M
Chief Operating Officer and Chief Legal Officer
Officer
Sell
-2,819 @ $1.14
($3,213.66)
 177,353 (-1.56%) Direct
11/04/2025
11/06/2025
Prior Stephen David
Chief Strategy Officer
Officer
Sell
-765 @ $1.14
($872.10)
 65,548 (-1.15%) Direct
06/02/2025
06/03/2025
Easom Eric
Chief Executive Officer
CEO Director
Buy
10,000 @ $1.07
$10,665.00
 256,380 (4.06%) Direct
05/28/2025
05/29/2025
Fitzpatrick Margaret M
Director
Buy
8,610 @ $1.18
$10,133.11
 8,610 (100.00%) Direct
01/03/2025
01/07/2025
Chanda Sanjay
Chief Development Officer
Officer
Sell
-2,957 @ $1.34
($3,965.34)
 29,824 (-9.02%) Direct
01/03/2025
01/07/2025
Day Lucy
Chief Financial Officer
CFO
Sell
-2,957 @ $1.34
($3,965.34)
 32,670 (-8.30%) Direct
01/03/2025
01/07/2025
Eizen Joshua M
Chief Operating Officer and Chief Legal Officer
Officer
Sell
-9,663 @ $1.34
($12,958.08)
 116,672 (-7.65%) Direct
01/03/2025
01/07/2025
Prior Stephen David
Chief Strategy Officer
Officer
Sell
-2,029 @ $1.34
($2,720.89)
 33,313 (-5.74%) Direct